Evidence map›Paper›PMID 40672191›Full record

ArticlebioRxiv : the preprint server for biology2025

Rapid Prototyping of Microfluidic Devices with Stereolithographic 3D Printing.

Hunter G Mason, Chih-Hsiang Hu, Leandro Soto Cordova, Ramin M Hakami, Remi Veneziano

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hunter G MasonSchool of System Biology, College of Science, George Mason University.ORCID 0009-0001-7485-5074
Chih-Hsiang HuDepartment of Bioengineering, College of Engineering and Computing, George Mason University.ORCID 0000-0002-6068-0728
Leandro Soto CordovaDepartment of Bioengineering, College of Engineering and Computing, George Mason University.ORCID 0009-0001-6193-5972
Ramin M HakamiSchool of System Biology, College of Science, George Mason University.ORCID 0000-0001-7122-0164
Remi VenezianoDepartment of Bioengineering, College of Engineering and Computing, George Mason University.ORCID 0000-0002-2726-3770

Funding

Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracisR42AI122666 · NIAID · INTEGRATED BIOTHERAPEUTICS, INC. · PI ADHIKARI, RAJAN P, HAKAMI, RAMIN M. · 2019 to 2021
$3.0M
Clinical Immersion with Health Professionals and Industry Advising in Undergraduate Biomedical Engineering Capstone DesignR25EB029381 · NIBIB · GEORGE MASON UNIVERSITY · PI ACUNA, SAMUEL, ROSS, SHANI · 2020 to 2025
$158k
NIAID NIH HHS R42 AI122666NIBIB NIH HHS R25 EB029381
6 · The paper itself

Abstract

3D printing has become a prevalent technology in many fields such as manufacturing, architecture, and electronics. This additive manufacturing technique is also widely used for biomedical research and clinical applications to prototype or assemble biomedical devices and tools. 3D printing-based strategies for biocompatible materials offer greater design flexibility, enhanced versatility, and faster results than traditional fabrication techniques, advantages that could be especially beneficial to the development of microfluidic chips. The ability to simply and efficiently produce new chip molds from computer aided design (CAD) models would significantly transform the development process and expand its accessibility by removing the need for more complex and expensive lithography methods. However, with standard processing strategies, the use of 3D printed molds for casting functioning chips is limited by the poor quality of prints achievable with widely available 3D printers. To mitigate this issue and facilitate rapid microfluidic device prototyping, we have developed a simple procedure to print microfluidic molds using a stereolithographic (SLA) printer and produce functional polydimethylsiloxane (PDMS) microfluidic chips with height and width feature dimensions as low as 75 μm. Molds printed using a commercially available liquid photopolymer-based resin and processed using our strategy exhibited high dimensional fidelity to intended designs and significantly reduced average surface roughness (< 3 μm). Here, we describe a streamlined post-print processing workflow for SLA molds and its efficacy in reducing surface roughness while preserving dimensional fidelity and then demonstrate its utility by prototyping and optimizing a microfluidic extracellular vesicle (EV)-exchange platform.

Indexed as

3D printingExtracellular vesicles (EVs)Laboratory-on-chip (LOC)Microfluidic devicesPolydimethylsiloxane (PDMS)Stereolithographic (SLA) printer

Identifiers

PMID40672191
PMCPMC12265651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.